Litcius/Paper detail

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

Jaime Feliú, Mónica Jorge Fernández, Teresa Macarulla, Bartomeu Massutí, Ana Albero, José Federico González González, G. Quintero Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montés, C García Piernavieja, Manuel Valladares‐Ayerbes, Ana María López Muñoz, Rebeca Mondéjar Solís, Pilar Vicente, E. González, Irene González Cebrián, Guillermo López-Vivanco

2021Cancer Chemotherapy and Pharmacology17 citationsDOI

Topics & Concepts

MedicineGemcitabineInternal medicineNeutropeniaInterquartile rangePopulationGastroenterologyPancreatic cancerPhases of clinical researchSurgeryClinical trialToxicityChemotherapyCancerEnvironmental healthPancreatic and Hepatic Oncology ResearchAdvances in Oncology and RadiotherapyCancer Treatment and Pharmacology
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study | Litcius